Please assess the completion status of the following clinical trial:

Trial Title: Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinically established ADPKD~* eGFR\>30ml/min.~* Chinese nationality~Exclusion Criteria:~* Uncontrolled infections~* Non-ADPKD complications

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- emodin (Type: ACTIVE_COMPARATOR): None
- Triptolide Woldifii (Type: EXPERIMENTAL): TW60mg/d

Based on this trial design, predict the completion outcome and termination type (if applicable).